Your browser doesn't support javascript.
loading
Management of Postprocedural Conduction Disturbances Using a Prespecified Algorithm in the Optimize PRO Study.
Grubb, Kendra J; Yakubov, Steven J; Nazif, Tamim M; Mittal, Suneet; Gada, Hemal; Fraser, Douglas G W; Rovin, Joshua D; Khalil, Ramzi; Pyo, Robert T; Sharma, Samin K; Ahmed, Mustafa; Huang, Jian; Rodes-Cabau, Josep.
Afiliação
  • Grubb KJ; Division of Cardiothoracic Surgery, Emory University, Atlanta, Georgia.
  • Yakubov SJ; Department of Interventional Cardiology, Riverside Methodist-OhioHealth, Columbus, Ohio.
  • Nazif TM; Division of Cardiology, Columbia University Medical Center, New York, New York.
  • Mittal S; Division of Cardiology and the Snyder Center for Comprehensive Atrial Fibrillation at Valley Health System, Ridgewood, New Jersey.
  • Gada H; Department of Interventional Cardiology, University of Pittsburgh Medical Center Pinnacle, Wormleyburg, Pennsylvania.
  • Fraser DGW; UK Manchester Heart Centre Central Manchester University Hospitals Cardiology Department, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Rovin JD; Department of Interventional Cardiology, Morton Plant Hospital, Clearwater, Florida.
  • Khalil R; Department of Cardiology, Allegheny General Hospital, Pittsburgh, Pennsylvania.
  • Pyo RT; Department of Interventional Cardiology, State University of New York at Stony Brook, Stony Brook, New York.
  • Sharma SK; Department of Interventional Cardiology, Mount Sinai Hospital, New York, New York.
  • Ahmed M; Department of Interventional Cardiology, University of Alabama at Birmingham Medicine, Birmingham, Alabama.
  • Huang J; Medtronic, Mounds View, Minnesota.
  • Rodes-Cabau J; Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
J Soc Cardiovasc Angiogr Interv ; 3(1): 101066, 2024 Jan.
Article em En | MEDLINE | ID: mdl-39131970
ABSTRACT

Background:

Lack of standardization in posttranscatheter aortic valve replacement (TAVR) conduction disturbance (CD) identification and treatment may affect permanent pacemaker implantation (PPI) rates and clinical outcomes. The safety and efficacy of a standardized TAVR CD algorithm has not been analyzed. This study analyzes the Optimize PRO post-TAVR CD management algorithm with Evolut PRO/PRO+ valves.

Methods:

Optimize PRO is a prospective, postmarket study implementing 2 strategies to reduce pacemaker rates TAVR with cusp overlap technique and a post-TAVR CD algorithm. The 2-hour postprocedural electrocardiogram (ECG) stratified patients to early discharge in the absence of new ECG changes or to CD algorithms for (1) ECG changes with preexisting right or left bundle branch block (LBBB), interventricular conduction delay or first-degree atrioventricular block, (2) new LBBB, or (3) high-degree atrioventricular block (HAVB).

Results:

The interim analysis of the CD cohort consisted of 125/400 TAVR recipients. In the CD cohort, the 30-day new PPI rate was higher (28.1% vs 1.5%; P <.001), and 60 (48%) patients were discharged with a 30-day continuous ECG monitor. At 30 days, 90% of patients discharged with a monitor did not require PPI. Clinical outcomes, including mortality, stroke, bleeding, and reintervention, were similar in patients with and without CDs. No patient experienced sudden cardiac death.

Conclusions:

Effective management of CDs using a standard algorithm following Evolut TAVR provides similar 30-day safety outcomes to patients without CDs who undergo routine next day discharge. The CD algorithm may provide an effective strategy to recognize arrhythmias early, improve PPI utilization, and facilitate safe monitoring of patients after discharge.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article